Structure Therapeutics, Inc. (GPCR)
49.96
+0.95
(+1.94%)
USD |
NASDAQ |
Aug 25, 16:00
49.96
0.00 (0.00%)
After-Hours: 19:59
Structure Therapeutics Price to Book Value : 2.627 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.577 |
| August 21, 2026 | 2.581 |
| August 20, 2026 | 2.656 |
| August 19, 2026 | 2.846 |
| August 18, 2026 | 2.815 |
| August 17, 2026 | 2.827 |
| August 14, 2026 | 2.866 |
| August 13, 2026 | 2.876 |
| August 12, 2026 | 2.835 |
| August 11, 2026 | 2.741 |
| August 10, 2026 | 2.829 |
| August 07, 2026 | 2.794 |
| August 06, 2026 | 2.767 |
| August 05, 2026 | 2.657 |
| August 04, 2026 | 2.610 |
| August 03, 2026 | 2.543 |
| July 31, 2026 | 2.526 |
| July 30, 2026 | 2.601 |
| July 29, 2026 | 2.490 |
| July 28, 2026 | 2.518 |
| July 27, 2026 | 2.560 |
| July 24, 2026 | 2.583 |
| July 23, 2026 | 2.671 |
| July 22, 2026 | 2.651 |
| July 21, 2026 | 2.595 |
| Date | Value |
|---|---|
| July 20, 2026 | 2.470 |
| July 17, 2026 | 2.549 |
| July 16, 2026 | 2.420 |
| July 15, 2026 | 2.609 |
| July 14, 2026 | 2.660 |
| July 13, 2026 | 2.715 |
| July 10, 2026 | 2.806 |
| July 09, 2026 | 2.899 |
| July 08, 2026 | 2.886 |
| July 07, 2026 | 2.978 |
| July 06, 2026 | 2.879 |
| July 02, 2026 | 2.810 |
| July 01, 2026 | 2.740 |
| June 30, 2026 | 2.822 |
| June 29, 2026 | 2.538 |
| June 26, 2026 | 2.441 |
| June 25, 2026 | 2.370 |
| June 24, 2026 | 2.365 |
| June 23, 2026 | 2.240 |
| June 22, 2026 | 2.235 |
| June 18, 2026 | 2.186 |
| June 17, 2026 | 2.21 |
| June 16, 2026 | 2.107 |
| June 15, 2026 | 2.115 |
| June 12, 2026 | 2.108 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 34.18 |
| Novo Nordisk A/S | 6.354 |
| Pfizer Inc. | 1.911 |
| Tarsus Pharmaceuticals, Inc. | 8.926 |
| Johnson & Johnson | 7.743 |
Price to Book Value Related Metrics
| Price | 49.96 |
| Earnings Yield | -6.17% |
| Market Cap | 3.558B |